An evaluation on clinical outline and management of mastalgia

Abstract

Introduction: Mastalgia is repeatedly associated with breast nodularity which may be soft or it may occur without a distinct lump. A quantity of
breast nodularity and mastalgia have been established in normal population. Materials and Methods: This study was conducted from May 2019 to June 2021. 110 patients were included in the study. A detailed study of clinical history of all the breast pathologies causing mastalgia was studied.Patients’ past records related to breast pain were noted in the OPD. During detailed clinical examination, if any lumps were observed suspicious of carcinoma then these patients were advised radiographic investigations. Results: Various causes of mastalgia were observed: 51 (46.3%)due to fibroadenosis, 14 (12.7%) due to fibroadenoma, 11 (10%) due to mastitis, 08(7.2%)duetobreastabscess,04(3.6%)due to duct ectasia, 03(2.7%) due to galactocoele, 02 (2.7%) due to breast carcinoma and 17(15.4%) due to non-specific extra-mammary cause. Conclusion: In this study, the response to therapy was best with danazol, followed by bromocriptine and to topical NSAIDs. Danazol and bromocriptine are effective in treatment of mastalgia, though they show different side effect profiles and varying patient compliance.